Zobrazeno 1 - 8
of 8
pro vyhledávání: '"I. G Gal"'
Publikováno v:
Medical and Social Expert Evaluation and Rehabilitation. 21:65-69
The article presents the main indices of the morbidity - the general prevalence and incidence in the Republic of South Ossetia over the period from 2012 to 2016 for the main classes, groups and specific types of diseases, as well as for individual so
Publikováno v:
Medical and Social Expert Evaluation and Rehabilitation. 19:172-177
Tasks of the organization of medical care at the present stage lie in the effective and economical use of available health care resources and in the increase of the accessibility and improvement of the quality of medical services. The effectiveness o
Autor:
S N, Puzin, M A, Shurgaya, S S, Memetov, R, Odebaeva, I G, Gal, G E, Pogosyan, N P, Sharkunov
Publikováno v:
Voprosy pitaniia. 88(6)
The problem of disability is associated with the problem of socially significant diseases, the main feature and at the same time the key characteristic of which is mass character. The epidemic nature of the spread and the medical and social burden of
Publikováno v:
Medical and Social Expert Evaluation and Rehabilitation. 19:216-218
Restorative medicine (RM) is based on principles of sanology, concepts of the preservation of human health (valeology) including occupational one. The origins of VM are SPA methods and systems of the restorative treatment (medical rehabilitation) wit
Publikováno v:
Anesteziologiya i Reanimatologiya. :45
Publikováno v:
Klinicheskaia meditsina. 92(4)
Presented is the description of the 41-year-old patient who was delivered to the emergency department of the clinical hospital. The patient has clinical manifestations of the stroke. Intracerebral hematoma of the right cerebral hemisphere was diagnos
Publikováno v:
Problemy tuberkuleza. (2)
A total of 108 patients with heart failure-complicated disseminated pulmonary tuberculosis were followed up. Fifty eight patients received combined therapy including the angiotensin-converting enzyme inhibitor ramipril in a daily dose of 0.25-0.50 mg
Publikováno v:
Fiziologiia cheloveka. 15(6)